ARK Investment Management LLC Makes New Investment in BrainsWay Ltd. (NASDAQ:BWAY)

ARK Investment Management LLC bought a new position in shares of BrainsWay Ltd. (NASDAQ:BWAY) during the fourth quarter, Holdings Channel.com reports. The fund bought 175,588 shares of the company’s stock, valued at approximately $1,656,000.

Separately, JPMorgan Chase & Co. grew its holdings in shares of BrainsWay by 316.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 14,769 shares of the company’s stock worth $136,000 after purchasing an additional 11,221 shares in the last quarter. Institutional investors and hedge funds own 30.11% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, HC Wainwright restated a “buy” rating and set a $16.00 price target on shares of BrainsWay in a research note on Monday, December 23rd.

BrainsWay Stock Down 0.3 %

BWAY stock opened at $9.75 on Thursday. BrainsWay Ltd. has a twelve month low of $4.61 and a twelve month high of $11.79. The company has a market cap of $183.46 million, a P/E ratio of 97.51 and a beta of 1.25. The business has a fifty day moving average of $10.17 and a 200-day moving average of $9.46.

About BrainsWay

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.